U.S. Insurance Stock News

IDEX (IEX) has drawn fresh attention after its Board approved a regular quarterly cash dividend of $0.73 per share, marking the company’s 127th consecutive quarterly payout to shareholders. See our latest analysis for IDEX. Alongside the dividend decision, IDEX has seen firm price momentum, with a 1 month share price return of 8.02%, a 3 month share price return of 22.26%, and a year to date share price return of 27.37%. The 1 year total shareholder return of 31.33% and 3 year total...

Edgewise Therapeutics recently reported positive top-line 12-week Phase 2 Part D CIRRUS-HCM results for EDG-7500 in both obstructive and nonobstructive hypertrophic cardiomyopathy, showing clinically meaningful improvements in hemodynamics, heart failure biomarkers, patient-reported outcomes and functional status, with generally well-tolerated safety. A distinctive aspect of these data is the apparent preservation of systolic function across more than 700 echocardiograms while still...

What Is Moving National HealthCare Stock Right Now? National HealthCare (NHC) has drawn investor attention recently as the stock price and valuation metrics have shifted. This is prompting a closer look at how its current market pricing compares with reported fundamentals. See our latest analysis for National HealthCare. Recent trading in National HealthCare shows strong momentum, with a 30 day share price return of 6.07%, a 90 day share price return of 25.15%, and a 1 year total shareholder...

Why ESAB’s New Board Roles Matter for Investors ESAB (ESAB) recently reshaped its board leadership, appointing Mitchell P. Rales as Executive Chair and Rhonda Jordan as Lead Independent Director. These moves focus attention on the company’s governance and ongoing transformation. For investors tracking ESAB stock, these appointments highlight how the board intends to organize oversight, clarify leadership roles, and support the existing management team as it pursues the company’s growth and...

Five Star Bancorp has opened a new full-service branch in Lodi, California, to deepen its banking support for local entrepreneurs and agribusinesses in the Central Valley. This move reinforces the bank’s focus on relationship-based lending in agriculture-rich communities, particularly vineyards and nut and cherry producers around Lodi. Next, we’ll examine how the Lodi branch opening, with its emphasis on agribusiness lending, may influence Five Star Bancorp’s investment narrative. Uncover...

Earlier this month, La-Z-Boy Incorporated reported fourth-quarter 2026 sales of US$570.34 million with net income of US$33.27 million, raised its quarterly dividend for the fifth consecutive year, launched a new US$300 million share repurchase authorization, and disclosed continued activity under its long-running buyback program. Together, higher quarterly earnings, ongoing dividend growth, and a sizable new repurchase plan underscore management’s commitment to returning cash to shareholders...

Autohome Inc. recently held its 2025 annual general meeting, where shareholders approved replacing the Seventh Amended and Restated Memorandum and Articles of Association with an Eighth edition and re‑elected key board members. This overhaul of the corporate bylaws, alongside management’s emphasis on user growth, new transaction features, and overseas platforms, could reshape how Autohome governs and scales its business. Next, we’ll examine how Autohome’s updated corporate bylaws and...

Regulators are turning up the heat on lithium batteries in everyday travel gear, from power banks to vapes, and that shift could matter for your portfolio. As scrutiny on safety rises, weaker suppliers may struggle to keep up, while certified battery manufacturers and established electronics brands could stand out with products that meet higher expectations. This article looks at how that changing backdrop connects to the Certified Battery Manufacturers & Electronic Device Brands screener and...

Alpha Tau Medical’s glioblastoma milestone and what it means for investors Alpha Tau Medical (NasdaqCM:DRTS) has attracted fresh investor attention after reporting the first successful Alpha DaRT treatment of a recurrent glioblastoma patient in Israel, and the first outside the United States. The procedure used the company’s brain specific delivery system at Hadassah University Medical Center in Jerusalem, targeting a recurrent tumor via a minimally invasive burr hole while maintaining real...

In recent weeks, Fannie Mae and Freddie Mac have expanded their retained investment portfolios, pushing their interest-rate risk exposure to levels reminiscent of the early 2000s as policymakers seek to lower mortgage rates by reducing mortgage-backed securities supply. This shift means the government-backed mortgage giants are now carrying materially higher sensitivity to sharp rate moves, even as they operate with larger capital buffers and smaller portfolios than before the 2008 financial...

Earlier this year, Stock Yards Bancorp reported quarterly revenues of US$102.6 million, representing 9.6% year-on-year growth, with net interest income matching analyst expectations. The bank emphasized that these results capped its best year in history and showed it entering 2026 with strong operating momentum. Next, we’ll examine how this revenue growth and “best year” commentary shape Stock Yards Bancorp’s investment narrative for investors. Capitalize on the AI infrastructure supercycle...

These clinical-stage biotech stocks focused on Parkinson's research feature treatments already in human trials, where clinical milestones could turn into meaningful share price catalysts.

Expeditors International of Washington stock has climbed 43.8% over the past year, yet the valuation checks point to a company that no longer looks obviously cheap, with the Discounted Cash Flow (DCF) estimate sitting close to the current share price while market multiples lean richer....

Earlier this week, Healthcare Foresights released a report projecting the global Laboratory Equipment Services Market to expand at an 8% CAGR to about US$62.83 billion by 2035, identifying Mettler-Toledo International as one of the key industry players. The report underscores how rising R&D spending, tighter regulatory compliance, and IoT-enabled service models could enhance demand for Mettler-Toledo’s laboratory equipment services offering over time. We’ll now explore how this projected...

Geothermal energy is moving from niche concept to front-page topic, as fresh US legislation, new drilling technology and rising interest from big tech and venture funds put the sector in the spotlight. For investors, that mix of political backing, technical progress and still challenging project economics creates both potential openings and clear risks. This article looks at how the latest geothermal news could affect listed companies tied to the sector, and breaks down 3 stocks from our...

Figma (FIG) kicked off its Config conference by rolling out AI powered updates that add a code layer, motion and shader support, and custom plug in options, pointing to a seat plus consumption pricing shift. See our latest analysis for Figma. Despite the fanfare around Figma’s new AI tools, the stock’s recent momentum has been weak, with the share price return down 9.66% over one day, 10.81% over seven days, and 55.22% year to date. This suggests the market is still reassessing growth...

Brunswick (BC) is back in focus after its Navico Group outlined cost cutting moves and Freedom Boat Club reached its 450th location, developments that coincided with a 4.2% one day share gain. See our latest analysis for Brunswick. The latest operational updates and boat club expansion come on top of a 90 day share price return of 23.97% and a 1 year total shareholder return of 62.33%. This points to positive momentum from both recent news and longer term performance. If Brunswick’s recent...

Dividend hike puts Banc of California in focus Banc of California (BANC) has moved into the spotlight after raising its dividend by 20%, supported by a payout ratio near 32%. CEO Jared Wolff has also emphasized momentum in the business. See our latest analysis for Banc of California. Alongside the dividend hike, Banc of California’s recent share price performance has been firm, with a 24.63% 3 month share price return and a 52.95% 1 year total shareholder return indicating building momentum...

Open-source AI is putting real pressure on closed, premium models, and that tension is starting to show up in stock prices. As customers question high AI service costs and regulators scrutinize leading frontier labs, investors are asking which companies might benefit if budgets and trust shift toward open platforms. This article looks at how the recent open-source AI news may affect listed companies that mention open-source AI in their business descriptions, and reveals 3 stocks that appear...

Geopolitical tension in the Strait of Hormuz has quickly shifted attention back to energy security, shipping routes and the companies tied to global oil flows. With the IMO pausing its Gulf evacuation plan after an Evergreen container ship attack and Iran reinforcing control over key sea lanes, investors are weighing how higher risk, disrupted traffic and rising insurance costs may affect valuations. This article looks at 3 stocks from an Energy Sector Stocks screener that are closely exposed...

Nuclear energy stocks sit at the crossroads of energy security, inflation pressures and shifting global policy signals. With commodity costs in focus, bond markets hinting at changing rate paths and energy trade balances back in the headlines, many investors are looking for power sources that can offer stable, large scale output. The Nuclear Energy Stocks screener filters for companies involved across the uranium and reactor supply chain, helping you focus quickly on liquid, listed...

Bank First stock reacts to recent performance trends Bank First (BFC) has drawn attention after a recent pullback of around 1% in the latest session, even as the stock shows gains over the past week, month, and past 3 months. See our latest analysis for Bank First. The recent 1 day share price decline of 1.05% sits against a stronger backdrop, with the year to date share price return at 20.12% and the 1 year total shareholder return at 26.21%, suggesting momentum has been building rather than...

Earlier this week, Cleveland-Cliffs faced softer sentiment after analysts trimmed their outlook on U.S. steel pricing and insiders disclosed US$2.90 million in recent share sales without any offsetting purchases. The combination of a more cautious analyst stance, insider selling, and consecutive days of underperformance versus the broader market has sharpened investor focus on how resilient Cleveland-Cliffs' tariff-supported and auto-heavy business model really is. We’ll now examine how the...

On June 17, 2026, CONMED Corporation announced that John E. Gallagher will become Executive Vice President and Chief Financial Officer, as well as principal financial and accounting officer, effective July 15, 2026. Gallagher’s broad background across healthcare and industrial companies, including senior finance roles at Certara, Cue Health, and Becton Dickinson, positions him to influence CONMED’s capital allocation, reporting quality, and investor communication. We’ll now examine how...